radiant and select: is adjuvant erlotinib effective in early-stage lung cancer?
Published 10 years ago • 219 plays • Length 16:43Download video MP4
Download video MP3
Similar videos
-
4:19
clinical trial spotlight: alchemist for early-stage alk and egfr lung cancer patients
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc
-
5:54
key points from the adaura trial: osimertinib - targeted therapies in lung cancer 2023
-
4:51
gracecast-116_lung-cancer_asco 2012 lc highlights: dr. neal on select trial of tarceva (erlotinib)
-
6:00
the adaura trial: 2023 updates - targeted therapies in lung cancer 2023
-
1:58
impower 010: adjuvant atezolizumab in nsclc - onctalk lung 2023
-
22:32
gracecast-022_lung-cancer_cancer lifeline lecture part 2 adjuvant chemo
-
5:12
adaura trial: tagrisso & resectable egfr - leading developments & current questions in lung cancer
-
1:57
keynote 091: adjuvant pembrolizumab - onctalk lung 2023
-
1:59:57
grace - global resource for advancing cancer education live stream
-
4:45
gracecastuc-019_lung_case in point: recommendation for adjuvant chemotherapy for high risk tumors
-
4:35
what is a standard adjuvant chemotherapy regimen?
-
2:12
neoadjuvant, perioperative, adjuvant: defining terms and advantages - onctalk lung 2023
-
2:32
segmentectomy for early stage nsclc - onctalk lung 2023
-
0:13
the importance of biomarker testing- targeted therapies in lung cancer 2023- #shorts #youtubeshorts
-
1:02
are egfr tkis (such as tarceva) effective in lung cancer patients who are wild type egfr?
-
3:02
the future of ret nsclc treatment - targeted therapies in lung cancer 2023
-
9:36
gracecast-021_lung-cancer_stage iiia management options
-
1:08
gracecastuc092_lung_dr. juergens on targeted therapy adjuvant early stage